Additionally, not all circulating PTH in patients with advanced CKD is biologically active, with a proportion of PTH undergoing oxidation thereby losing biological activity (Hocher et al., 2013), and circulating PTH has an extremely short half-life (minutes), therefore PTH levels fluctuate significantly and a trend rather than a single value is more useful to monitor SHPT progression. This evidence concerns the gene PTH and chronic kidney disease.